EE9800141A - Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena - Google Patents

Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena

Info

Publication number
EE9800141A
EE9800141A EE9800141A EE9800141A EE9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A EE 9800141 A EE9800141 A EE 9800141A
Authority
EE
Estonia
Prior art keywords
amidine
nitric oxide
oxide synthase
synthase inhibitors
isothiourea derivatives
Prior art date
Application number
EE9800141A
Other languages
English (en)
Inventor
Macdonald James
Shakespeare William
Matz James
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9600275A external-priority patent/SE9600275D0/xx
Priority claimed from SE9603301A external-priority patent/SE9603301D0/xx
Priority claimed from SE9603300A external-priority patent/SE9603300D0/xx
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of EE9800141A publication Critical patent/EE9800141A/et

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treating Waste Gases (AREA)
  • Exhaust Gas Treatment By Means Of Catalyst (AREA)
  • Gas Separation By Absorption (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
EE9800141A 1995-11-07 1996-11-06 Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena EE9800141A (et)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US625395P 1995-11-07 1995-11-07
US627695P 1995-11-07 1995-11-07
SE9600275A SE9600275D0 (sv) 1996-01-25 1996-01-25 Compounds
SE9603301A SE9603301D0 (sv) 1996-09-11 1996-09-11 Compounds and compositions
SE9603300A SE9603300D0 (sv) 1996-09-11 1996-09-11 Compounds
PCT/SE1996/001425 WO1997017344A1 (en) 1995-11-07 1996-11-06 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase

Publications (1)

Publication Number Publication Date
EE9800141A true EE9800141A (et) 1998-10-15

Family

ID=27532790

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800141A EE9800141A (et) 1995-11-07 1996-11-06 Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena

Country Status (24)

Country Link
EP (1) EP0861250B1 (et)
JP (1) JP2000500132A (et)
KR (1) KR19990067349A (et)
AT (1) ATE213241T1 (et)
AU (1) AU701329B2 (et)
BR (1) BR9611276A (et)
CA (1) CA2235301A1 (et)
CZ (1) CZ139298A3 (et)
DE (1) DE69619259T2 (et)
DK (1) DK0861250T3 (et)
EE (1) EE9800141A (et)
ES (1) ES2171743T3 (et)
HU (1) HUP9900142A3 (et)
IL (1) IL124296A0 (et)
IS (1) IS4725A (et)
NO (1) NO982072L (et)
NZ (1) NZ322227A (et)
PL (1) PL326554A1 (et)
PT (1) PT861250E (et)
SI (1) SI0861250T1 (et)
SK (1) SK61098A3 (et)
TR (1) TR199800813T2 (et)
TW (1) TW458978B (et)
WO (1) WO1997017344A1 (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998016526A1 (en) * 1996-10-16 1998-04-23 Glaxo Group Limited Tetrahydro-6h-pyrazino[1,2-b]isoquinoline 1,4-diones as apoprotein b-100 inhibitors
SE9701681D0 (sv) 1997-05-05 1997-05-05 Astra Ab New compounds
SE9901901D0 (sv) * 1999-05-26 1999-05-26 Astra Ab Compounds
JP2005518378A (ja) * 2001-12-19 2005-06-23 ハー・ルンドベック・アクチエゼルスカベット 3,4−ジヒドロ−ih−イソキノリン−2−イル誘導体
US6608193B2 (en) * 2001-12-21 2003-08-19 The Procter & Gamble Company Methods for synthesis of amino-tetrahydroisoquinoline ring compounds
AU2003257300B2 (en) * 2002-08-07 2010-01-21 Neuraxon Inc. Amino benzothiazole compounds with NOS inhibitory activity
US8710045B2 (en) 2004-01-22 2014-04-29 The Trustees Of Columbia University In The City Of New York Agents for preventing and treating disorders involving modulation of the ryanodine receptors
CN101258135A (zh) * 2005-07-05 2008-09-03 阿斯利康(瑞典)有限公司 新化合物、其制备方法、中间体、药物组合物和其在治疗5-ht6介导的疾病例如阿尔茨海默病、认知障碍、精神分裂症相关的认知缺损、肥胖和帕金森病中的用途
WO2008108445A1 (ja) 2007-03-07 2008-09-12 Takeda Pharmaceutical Company Limited ベンゾオキサゼピン誘導体およびその用途
BR112019012782A2 (pt) 2016-12-23 2020-03-31 Daiichi Sankyo Company, Limited Composto, composição farmacêutica, inibidor de tnap, uso de um composto, e, método para tratamento ou profilaxia de uma doença ou condição e para inibir tnap em um indivíduo.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09504278A (ja) * 1944-06-01 1997-04-28 ザ、ウェルカム、ファンデーション、リミテッド Noシンターゼインヒビターとしての置換尿素およびイソチオ尿素誘導体
ES2132393T3 (es) * 1993-03-23 1999-08-16 Astra Ab Derivados de guanidina utiles en terapeutica.
SK16396A3 (en) * 1993-08-12 1996-09-04 Astra Ab Amidine derivatives with nitric oxide synthetase activities
TW397812B (en) * 1995-02-11 2000-07-11 Astra Ab Bicyclic isothiourea derivatives useful in therapy

Also Published As

Publication number Publication date
EP0861250B1 (en) 2002-02-13
PT861250E (pt) 2002-07-31
CZ139298A3 (cs) 1998-09-16
DE69619259T2 (de) 2002-09-19
DK0861250T3 (da) 2002-04-29
NO982072L (no) 1998-07-03
PL326554A1 (en) 1998-09-28
EP0861250A1 (en) 1998-09-02
DE69619259D1 (de) 2002-03-21
MX9803453A (es) 1998-09-30
IL124296A0 (en) 1998-12-06
HUP9900142A2 (hu) 1999-05-28
SI0861250T1 (en) 2002-06-30
ATE213241T1 (de) 2002-02-15
NZ322227A (en) 1999-11-29
KR19990067349A (ko) 1999-08-16
JP2000500132A (ja) 2000-01-11
TR199800813T2 (xx) 1998-07-21
SK61098A3 (en) 1999-01-11
ES2171743T3 (es) 2002-09-16
IS4725A (is) 1998-04-24
AU7592796A (en) 1997-05-29
TW458978B (en) 2001-10-11
WO1997017344A1 (en) 1997-05-15
CA2235301A1 (en) 1997-05-15
NO982072D0 (no) 1998-05-06
AU701329B2 (en) 1999-01-28
BR9611276A (pt) 1999-01-26
HUP9900142A3 (en) 2001-08-28

Similar Documents

Publication Publication Date Title
DK0530087T3 (da) Hidtil ukendte naphthylethylurinstof- og naphthylethylthiourinstofforbindelser, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO996108L (no) 9-oksinerytromycinderivater
SE0302323D0 (sv) Novel compounds
SE9803518D0 (sv) Novel compounds
NO984470L (no) Pyrrolopyrrolon-derivater som inhibitorer for neutrofil elastase
ES2134801T3 (es) Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso.
EE9800141A (et) Amidiini ja isotiokarbamiidi derivaadid lämmastikoksiidi süntaasi inhibiitoritena
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
DK0490816T3 (da) Fluorforbindelser som aromatase-inhibitorer.
DK624989D0 (da) Hidtil ukendte forbindelser
DE69330601T2 (de) Serotoninergische ergolin derivate
TR199902720T2 (xx) Nitrik oksit sentaz�n�n inhibit�rleri olarak amidin t�revleri.
SE9901901D0 (sv) Compounds
AU2001234314A1 (en) Novel phenylheteroalkylamine derivatives
SE9904676D0 (sv) Novel compounds
AU7935887A (en) Therapeutic agent for the treatment of peptic ulcer disease
ES2095431T3 (es) N-(isoquinolein-5-il)-sulfonil-azacicloalcanos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SE0102640D0 (sv) Novel compounds
SE9904677D0 (sv) Novel compounds
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
SE0000477D0 (sv) Novel compounds
SE9802650D0 (sv) Compounds